NCT07849816Not yet recruiting
Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological Determinants
Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological Determinants: A Multicenter Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
Multiple sclerosis (MS) and functional neurological disorders (FND) share clinical features, which may result in FND being overlooked in patients with MS. They also share common comorbidities, including depression and alexithymia. As their management differs, assessing the frequency and determinants of FND in patients with MS is important to improve diagnosis and ensure appropriate management.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 24 Sept 2026
- Start date
- 2 Oct 2026
- Primary completion date
- 1 Oct 2027
- Lead sponsor
- University Hospital, Strasbourg, France
- Diseases
- Multiple sclerosis
- NCT number
- NCT07849816
What you commit to
- Study type: Observational
- Planned participants: 100
- From 2 Oct 2026 to the primary completion date, 1 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known severe psychotic disorder
Other
- Patient unwilling to participate in the study
- Patient under judicial protection (sauvegarde de justice)
- Patient under guardianship or curatorship (tutelle or curatelle)
Who the study is looking for
- Adult patient (≥ 18 years of age)
- Diagnosis of multiple sclerosis (MS) according to the 2024 McDonald criteria
- Stable brain MRI performed within the previous 12 months
- No relapse between the MRI and study enrollment
- Ability to understand French
- Affiliated with the French national health insurance system
- Willing to participate in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.